Get the Stockscreener App
1.68
1.18%
-0.02
After Hours:
1.70
0.02
+1.19%
MAIA Biotechnology Inc stock is traded at $1.68, with a volume of 605.80K.
It is down -1.18% in the last 24 hours and up +7.01% over the past month.
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.
See More
Previous Close:
$1.70
Open:
$1.71
24h Volume:
605.80K
Relative Volume:
1.32
Market Cap:
$55.43M
Revenue:
-
Net Income/Loss:
$-25.94M
P/E Ratio:
-1.2174
EPS:
-1.38
Net Cash Flow:
$-15.79M
1W Performance:
+9.09%
1M Performance:
+7.01%
6M Performance:
+5.00%
1Y Performance:
-48.31%
1-Day Range:
$1.64
$1.75
1-Week Range:
$1.52
$1.78
52-Week Range:
$1.40
$3.48
MAIA Biotechnology Inc Stock (MAIA) Company Profile
Name
MAIA Biotechnology Inc
Sector
Industry
Phone
312 416 8592
Address
444 West Lake Street, Suite 1700, Chicago
Compare MAIA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.68 | 51.47M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
MAIA Biotechnology Inc Stock (MAIA) Latest News
How to integrate MAIA Biotechnology Inc. into portfolio analysis tools2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
What the charts say about MAIA Biotechnology Inc. todayEarnings Risk Summary & Weekly Watchlist for Consistent Profits - Newser
Short interest data insights for MAIA Biotechnology Inc.Market Movers & Low Drawdown Momentum Ideas - Newser
MAIA Biotechnology Updates Business Presentation Online - TipRanks
MAIA Biotechnology Inc. stock volume spike explainedPortfolio Performance Report & Daily Profit Focused Stock Screening - Newser
What Fibonacci levels say about MAIA Biotechnology Inc. rebound2025 Market Trends & Technical Buy Zone Confirmation - Newser
What earnings revisions data tells us about MAIA Biotechnology Inc.Rate Cut & Daily Profit Maximizing Trade Tips - Newser
Published on: 2025-09-12 05:24:13 - Newser
Using economic indicators to assess MAIA Biotechnology Inc. potentialQuarterly Trade Report & Proven Capital Preservation Methods - Newser
Using portfolio simulators with MAIA Biotechnology Inc. included2025 Market WrapUp & Safe Entry Zone Tips - Newser
Is a relief rally coming for MAIA Biotechnology Inc. holdersJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
Will earnings trigger a reversal in MAIA Biotechnology Inc.Weekly Trend Summary & Community Driven Trade Alerts - Newser
What recovery options are there for MAIA Biotechnology Inc.Long Setup & Accurate Technical Buy Alerts - Newser
MAIA Biotechnology Reports Positive Phase 2 Trial Results - TipRanks
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer - The Manila Times
MAIA Biotechnology Highlights Positive Efficacy Data from - GlobeNewswire
124% Survival Improvement: MAIA Biotechnology's Lung Cancer Drug Doubles Standard Care Effectiveness - Stock Titan
Intraday pattern recognizer results for MAIA Biotechnology Inc.Market Activity Report & Expert-Curated Trade Recommendations - Newser
Heatmap analysis for MAIA Biotechnology Inc. and competitorsQuarterly Trade Summary & Precise Swing Trade Alerts - Newser
Published on: 2025-09-10 00:28:01 - Newser
Is MAIA Biotechnology Inc. reversing from oversold territoryJuly 2025 Reactions & High Conviction Investment Ideas - Newser
Comparing MAIA Biotechnology Inc. in custom built stock radarsJuly 2025 Levels & Accurate Intraday Trading Signals - Newser
Is MAIA Biotechnology Inc. stock a growth or value playWeekly Trade Recap & Stock Portfolio Risk Management - Newser
Strategies to average down on MAIA Biotechnology Inc.Weekly Trade Review & Verified Technical Signals - Newser
Does MAIA Biotechnology Inc. have pricing powerWatch List & Safe Capital Growth Plans - Lancaster City Council
Has MAIA Biotechnology Inc. formed a bullish divergenceInsider Selling & Smart Allocation Stock Tips - Newser
using portfolio simulators with maia biotechnology inc. includedAnalyst Downgrade & Safe Swing Trade Setup Alerts - Newser
Published on: 2025-09-09 02:06:15 - Newser
Order flow analysis tools used on MAIA Biotechnology Inc.July 2025 Summary & Free Daily Entry Point Trade Alerts - Newser
Maia Biotechnology presents Phase 2 THIO-101 trial data at lung cancer conference - Investing.com Australia
MAIA Biotechnology Inc Stock (MAIA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Cap:
|
Volume (24h):